Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

Caffeine's Effect on Regadenoson Administration With Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
A Phase 3b, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Caffeine Intake on Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI) in Subjects Administered Regadenoson
Status: Enrolling
Updated:  11/20/2017
Clinical Research Facility
mi
from
Kansas City, MO
Caffeine's Effect on Regadenoson Administration With Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
A Phase 3b, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Caffeine Intake on Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI) in Subjects Administered Regadenoson
Status: Enrolling
Updated: 11/20/2017
Clinical Research Facility
mi
from
Kansas City, MO
Click here to add this to my saved trials
Caffeine's Effect on Regadenoson Administration With Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
A Phase 3b, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Caffeine Intake on Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI) in Subjects Administered Regadenoson
Status: Enrolling
Updated:  11/20/2017
Clinical Research Facility
mi
from
Albany, NY
Caffeine's Effect on Regadenoson Administration With Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
A Phase 3b, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Caffeine Intake on Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI) in Subjects Administered Regadenoson
Status: Enrolling
Updated: 11/20/2017
Clinical Research Facility
mi
from
Albany, NY
Click here to add this to my saved trials
Caffeine's Effect on Regadenoson Administration With Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
A Phase 3b, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Caffeine Intake on Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI) in Subjects Administered Regadenoson
Status: Enrolling
Updated:  11/20/2017
Clinical Research Facility
mi
from
Rochester, NY
Caffeine's Effect on Regadenoson Administration With Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
A Phase 3b, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Caffeine Intake on Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI) in Subjects Administered Regadenoson
Status: Enrolling
Updated: 11/20/2017
Clinical Research Facility
mi
from
Rochester, NY
Click here to add this to my saved trials
Caffeine's Effect on Regadenoson Administration With Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
A Phase 3b, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Caffeine Intake on Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI) in Subjects Administered Regadenoson
Status: Enrolling
Updated:  11/20/2017
Clinical Research Facility
mi
from
Columbus, OH
Caffeine's Effect on Regadenoson Administration With Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
A Phase 3b, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Caffeine Intake on Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI) in Subjects Administered Regadenoson
Status: Enrolling
Updated: 11/20/2017
Clinical Research Facility
mi
from
Columbus, OH
Click here to add this to my saved trials
Caffeine's Effect on Regadenoson Administration With Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
A Phase 3b, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Caffeine Intake on Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI) in Subjects Administered Regadenoson
Status: Enrolling
Updated:  11/20/2017
Clinical Research Facility
mi
from
Philadelphia, PA
Caffeine's Effect on Regadenoson Administration With Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
A Phase 3b, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Caffeine Intake on Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI) in Subjects Administered Regadenoson
Status: Enrolling
Updated: 11/20/2017
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Caffeine's Effect on Regadenoson Administration With Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
A Phase 3b, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Caffeine Intake on Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI) in Subjects Administered Regadenoson
Status: Enrolling
Updated:  11/20/2017
Clinical Research Facility
mi
from
Wyomissing, PA
Caffeine's Effect on Regadenoson Administration With Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
A Phase 3b, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Caffeine Intake on Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI) in Subjects Administered Regadenoson
Status: Enrolling
Updated: 11/20/2017
Clinical Research Facility
mi
from
Wyomissing, PA
Click here to add this to my saved trials
Caffeine's Effect on Regadenoson Administration With Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
A Phase 3b, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Caffeine Intake on Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI) in Subjects Administered Regadenoson
Status: Enrolling
Updated:  11/20/2017
Clinical Research Facility
mi
from
Knoxville, TN
Caffeine's Effect on Regadenoson Administration With Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
A Phase 3b, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Caffeine Intake on Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI) in Subjects Administered Regadenoson
Status: Enrolling
Updated: 11/20/2017
Clinical Research Facility
mi
from
Knoxville, TN
Click here to add this to my saved trials
A Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging (MPI) Using Multidetector Computed Tomography (MDCT) Compared to Single Photon Emission Computed Tomography (SPECT)
A Phase 2, Open-Label, Randomized, Cross-Over Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging by Multidetector Computed Tomography (MDCT) and Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated:  11/21/2017
Sutter Roseville Medical Center
mi
from
Roseville, CA
A Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging (MPI) Using Multidetector Computed Tomography (MDCT) Compared to Single Photon Emission Computed Tomography (SPECT)
A Phase 2, Open-Label, Randomized, Cross-Over Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging by Multidetector Computed Tomography (MDCT) and Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated: 11/21/2017
Sutter Roseville Medical Center
mi
from
Roseville, CA
Click here to add this to my saved trials
A Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging (MPI) Using Multidetector Computed Tomography (MDCT) Compared to Single Photon Emission Computed Tomography (SPECT)
A Phase 2, Open-Label, Randomized, Cross-Over Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging by Multidetector Computed Tomography (MDCT) and Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated:  11/21/2017
Harbor UCLA Medical Center
mi
from
Torrance, CA
A Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging (MPI) Using Multidetector Computed Tomography (MDCT) Compared to Single Photon Emission Computed Tomography (SPECT)
A Phase 2, Open-Label, Randomized, Cross-Over Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging by Multidetector Computed Tomography (MDCT) and Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated: 11/21/2017
Harbor UCLA Medical Center
mi
from
Torrance, CA
Click here to add this to my saved trials
A Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging (MPI) Using Multidetector Computed Tomography (MDCT) Compared to Single Photon Emission Computed Tomography (SPECT)
A Phase 2, Open-Label, Randomized, Cross-Over Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging by Multidetector Computed Tomography (MDCT) and Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated:  11/21/2017
Cardiovascular Research Center of South Florida
mi
from
Miami, FL
A Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging (MPI) Using Multidetector Computed Tomography (MDCT) Compared to Single Photon Emission Computed Tomography (SPECT)
A Phase 2, Open-Label, Randomized, Cross-Over Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging by Multidetector Computed Tomography (MDCT) and Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated: 11/21/2017
Cardiovascular Research Center of South Florida
mi
from
Miami, FL
Click here to add this to my saved trials
A Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging (MPI) Using Multidetector Computed Tomography (MDCT) Compared to Single Photon Emission Computed Tomography (SPECT)
A Phase 2, Open-Label, Randomized, Cross-Over Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging by Multidetector Computed Tomography (MDCT) and Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated:  11/21/2017
Baptist Hospital of Miami
mi
from
Miami, FL
A Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging (MPI) Using Multidetector Computed Tomography (MDCT) Compared to Single Photon Emission Computed Tomography (SPECT)
A Phase 2, Open-Label, Randomized, Cross-Over Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging by Multidetector Computed Tomography (MDCT) and Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated: 11/21/2017
Baptist Hospital of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
A Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging (MPI) Using Multidetector Computed Tomography (MDCT) Compared to Single Photon Emission Computed Tomography (SPECT)
A Phase 2, Open-Label, Randomized, Cross-Over Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging by Multidetector Computed Tomography (MDCT) and Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated:  11/21/2017
Midwest Cardiology Associates, P.C.
mi
from
Overland Park, KA
A Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging (MPI) Using Multidetector Computed Tomography (MDCT) Compared to Single Photon Emission Computed Tomography (SPECT)
A Phase 2, Open-Label, Randomized, Cross-Over Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging by Multidetector Computed Tomography (MDCT) and Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated: 11/21/2017
Midwest Cardiology Associates, P.C.
mi
from
Overland Park, KA
Click here to add this to my saved trials
A Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging (MPI) Using Multidetector Computed Tomography (MDCT) Compared to Single Photon Emission Computed Tomography (SPECT)
A Phase 2, Open-Label, Randomized, Cross-Over Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging by Multidetector Computed Tomography (MDCT) and Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated:  11/21/2017
Maine Research Associates
mi
from
Auburn, ME
A Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging (MPI) Using Multidetector Computed Tomography (MDCT) Compared to Single Photon Emission Computed Tomography (SPECT)
A Phase 2, Open-Label, Randomized, Cross-Over Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging by Multidetector Computed Tomography (MDCT) and Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated: 11/21/2017
Maine Research Associates
mi
from
Auburn, ME
Click here to add this to my saved trials
A Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging (MPI) Using Multidetector Computed Tomography (MDCT) Compared to Single Photon Emission Computed Tomography (SPECT)
A Phase 2, Open-Label, Randomized, Cross-Over Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging by Multidetector Computed Tomography (MDCT) and Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated:  11/21/2017
Massachusetts General Hospital
mi
from
Boston, MA
A Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging (MPI) Using Multidetector Computed Tomography (MDCT) Compared to Single Photon Emission Computed Tomography (SPECT)
A Phase 2, Open-Label, Randomized, Cross-Over Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging by Multidetector Computed Tomography (MDCT) and Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated: 11/21/2017
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
A Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging (MPI) Using Multidetector Computed Tomography (MDCT) Compared to Single Photon Emission Computed Tomography (SPECT)
A Phase 2, Open-Label, Randomized, Cross-Over Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging by Multidetector Computed Tomography (MDCT) and Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated:  11/21/2017
Brigham and Women's Hosp
mi
from
Boston, MA
A Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging (MPI) Using Multidetector Computed Tomography (MDCT) Compared to Single Photon Emission Computed Tomography (SPECT)
A Phase 2, Open-Label, Randomized, Cross-Over Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging by Multidetector Computed Tomography (MDCT) and Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated: 11/21/2017
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
A Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging (MPI) Using Multidetector Computed Tomography (MDCT) Compared to Single Photon Emission Computed Tomography (SPECT)
A Phase 2, Open-Label, Randomized, Cross-Over Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging by Multidetector Computed Tomography (MDCT) and Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated:  11/21/2017
Berkshire Medical Center
mi
from
Pittsfield, MA
A Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging (MPI) Using Multidetector Computed Tomography (MDCT) Compared to Single Photon Emission Computed Tomography (SPECT)
A Phase 2, Open-Label, Randomized, Cross-Over Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging by Multidetector Computed Tomography (MDCT) and Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated: 11/21/2017
Berkshire Medical Center
mi
from
Pittsfield, MA
Click here to add this to my saved trials
A Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging (MPI) Using Multidetector Computed Tomography (MDCT) Compared to Single Photon Emission Computed Tomography (SPECT)
A Phase 2, Open-Label, Randomized, Cross-Over Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging by Multidetector Computed Tomography (MDCT) and Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated:  11/21/2017
Henry Ford Health System
mi
from
Detroit, MI
A Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging (MPI) Using Multidetector Computed Tomography (MDCT) Compared to Single Photon Emission Computed Tomography (SPECT)
A Phase 2, Open-Label, Randomized, Cross-Over Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging by Multidetector Computed Tomography (MDCT) and Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated: 11/21/2017
Henry Ford Health System
mi
from
Detroit, MI
Click here to add this to my saved trials
A Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging (MPI) Using Multidetector Computed Tomography (MDCT) Compared to Single Photon Emission Computed Tomography (SPECT)
A Phase 2, Open-Label, Randomized, Cross-Over Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging by Multidetector Computed Tomography (MDCT) and Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated:  11/21/2017
Oregon Health and Science University
mi
from
Portland, OR
A Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging (MPI) Using Multidetector Computed Tomography (MDCT) Compared to Single Photon Emission Computed Tomography (SPECT)
A Phase 2, Open-Label, Randomized, Cross-Over Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging by Multidetector Computed Tomography (MDCT) and Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated: 11/21/2017
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
OCT Screening for Diabetic Macular Edema at Primary Diabetes Care Visits
Diabetic Macular Edema Found by OCT Utilization at Non-ophthalmic Diabetes Care Visits
Status: Enrolling
Updated:  11/22/2017
Joslin Diabetes Center
mi
from
Boston, MA
OCT Screening for Diabetic Macular Edema at Primary Diabetes Care Visits
Diabetic Macular Edema Found by OCT Utilization at Non-ophthalmic Diabetes Care Visits
Status: Enrolling
Updated: 11/22/2017
Joslin Diabetes Center
mi
from
Boston, MA
Click here to add this to my saved trials
OCT Screening for Diabetic Macular Edema at Primary Diabetes Care Visits
Diabetic Macular Edema Found by OCT Utilization at Non-ophthalmic Diabetes Care Visits
Status: Enrolling
Updated:  11/22/2017
OuterCape Health Services, Inc
mi
from
Wellfleet, MA
OCT Screening for Diabetic Macular Edema at Primary Diabetes Care Visits
Diabetic Macular Edema Found by OCT Utilization at Non-ophthalmic Diabetes Care Visits
Status: Enrolling
Updated: 11/22/2017
OuterCape Health Services, Inc
mi
from
Wellfleet, MA
Click here to add this to my saved trials
OCT Screening for Diabetic Macular Edema at Primary Diabetes Care Visits
Diabetic Macular Edema Found by OCT Utilization at Non-ophthalmic Diabetes Care Visits
Status: Enrolling
Updated:  11/22/2017
SUNY Upstate Medical University
mi
from
Syracuse, NY
OCT Screening for Diabetic Macular Edema at Primary Diabetes Care Visits
Diabetic Macular Edema Found by OCT Utilization at Non-ophthalmic Diabetes Care Visits
Status: Enrolling
Updated: 11/22/2017
SUNY Upstate Medical University
mi
from
Syracuse, NY
Click here to add this to my saved trials
OCT Screening for Diabetic Macular Edema at Primary Diabetes Care Visits
Diabetic Macular Edema Found by OCT Utilization at Non-ophthalmic Diabetes Care Visits
Status: Enrolling
Updated:  11/22/2017
University of Endocrine Consultants
mi
from
Chattanooga, TN
OCT Screening for Diabetic Macular Edema at Primary Diabetes Care Visits
Diabetic Macular Edema Found by OCT Utilization at Non-ophthalmic Diabetes Care Visits
Status: Enrolling
Updated: 11/22/2017
University of Endocrine Consultants
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Diagnostic Accuracy of Multislice CT Angiography for Acute Chest Pain
Diagnostic Accuracy of Multislice CT Angiography for Acute Chest Pain - Assessment of Chest Pain Utilizing a Triple Rule Out Evaluation With Computed Tomography (ACUTE CT) Trial
Status: Enrolling
Updated:  11/22/2017
University of Washington Medical Center
mi
from
Seattle, WA
Diagnostic Accuracy of Multislice CT Angiography for Acute Chest Pain
Diagnostic Accuracy of Multislice CT Angiography for Acute Chest Pain - Assessment of Chest Pain Utilizing a Triple Rule Out Evaluation With Computed Tomography (ACUTE CT) Trial
Status: Enrolling
Updated: 11/22/2017
University of Washington Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Safety of Low Dose IV Contrast CT Scanning in Chronic Kidney Disease
Safety of Low Dose Intravenous Contrast 64 Multi-Detector Computed Tomography Scanning in Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  11/26/2017
VA Greater Los Angeles Healthcare System
mi
from
Los Angeles, CA
Safety of Low Dose IV Contrast CT Scanning in Chronic Kidney Disease
Safety of Low Dose Intravenous Contrast 64 Multi-Detector Computed Tomography Scanning in Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 11/26/2017
VA Greater Los Angeles Healthcare System
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Belimumab in Remission of VASculitis
A Phase 3, Multi-Center, Multinational, Randomized, Double-Blind, Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) in Combination With Azathioprine for the Maintenance of Remission in Wegener's Granulomatosis and Microscopic Polyangiitis
Status: Enrolling
Updated:  11/27/2017
GSK Investigational Site
mi
from
Birmingham, AL
Belimumab in Remission of VASculitis
A Phase 3, Multi-Center, Multinational, Randomized, Double-Blind, Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) in Combination With Azathioprine for the Maintenance of Remission in Wegener's Granulomatosis and Microscopic Polyangiitis
Status: Enrolling
Updated: 11/27/2017
GSK Investigational Site
mi
from
Birmingham, AL
Click here to add this to my saved trials
Belimumab in Remission of VASculitis
A Phase 3, Multi-Center, Multinational, Randomized, Double-Blind, Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) in Combination With Azathioprine for the Maintenance of Remission in Wegener's Granulomatosis and Microscopic Polyangiitis
Status: Enrolling
Updated:  11/27/2017
GSK Investigational Site
mi
from
Tucson, AZ
Belimumab in Remission of VASculitis
A Phase 3, Multi-Center, Multinational, Randomized, Double-Blind, Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) in Combination With Azathioprine for the Maintenance of Remission in Wegener's Granulomatosis and Microscopic Polyangiitis
Status: Enrolling
Updated: 11/27/2017
GSK Investigational Site
mi
from
Tucson, AZ
Click here to add this to my saved trials
Belimumab in Remission of VASculitis
A Phase 3, Multi-Center, Multinational, Randomized, Double-Blind, Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) in Combination With Azathioprine for the Maintenance of Remission in Wegener's Granulomatosis and Microscopic Polyangiitis
Status: Enrolling
Updated:  11/27/2017
GSK Investigational Site
mi
from
Covina, CA
Belimumab in Remission of VASculitis
A Phase 3, Multi-Center, Multinational, Randomized, Double-Blind, Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) in Combination With Azathioprine for the Maintenance of Remission in Wegener's Granulomatosis and Microscopic Polyangiitis
Status: Enrolling
Updated: 11/27/2017
GSK Investigational Site
mi
from
Covina, CA
Click here to add this to my saved trials
Belimumab in Remission of VASculitis
A Phase 3, Multi-Center, Multinational, Randomized, Double-Blind, Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) in Combination With Azathioprine for the Maintenance of Remission in Wegener's Granulomatosis and Microscopic Polyangiitis
Status: Enrolling
Updated:  11/27/2017
GSK Investigational Site
mi
from
Palo Alto, CA
Belimumab in Remission of VASculitis
A Phase 3, Multi-Center, Multinational, Randomized, Double-Blind, Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) in Combination With Azathioprine for the Maintenance of Remission in Wegener's Granulomatosis and Microscopic Polyangiitis
Status: Enrolling
Updated: 11/27/2017
GSK Investigational Site
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Belimumab in Remission of VASculitis
A Phase 3, Multi-Center, Multinational, Randomized, Double-Blind, Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) in Combination With Azathioprine for the Maintenance of Remission in Wegener's Granulomatosis and Microscopic Polyangiitis
Status: Enrolling
Updated:  11/27/2017
GSK Investigational Site
mi
from
San Leandro, CA
Belimumab in Remission of VASculitis
A Phase 3, Multi-Center, Multinational, Randomized, Double-Blind, Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) in Combination With Azathioprine for the Maintenance of Remission in Wegener's Granulomatosis and Microscopic Polyangiitis
Status: Enrolling
Updated: 11/27/2017
GSK Investigational Site
mi
from
San Leandro, CA
Click here to add this to my saved trials
Belimumab in Remission of VASculitis
A Phase 3, Multi-Center, Multinational, Randomized, Double-Blind, Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) in Combination With Azathioprine for the Maintenance of Remission in Wegener's Granulomatosis and Microscopic Polyangiitis
Status: Enrolling
Updated:  11/27/2017
GSK Investigational Site
mi
from
Kansas City, KA
Belimumab in Remission of VASculitis
A Phase 3, Multi-Center, Multinational, Randomized, Double-Blind, Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) in Combination With Azathioprine for the Maintenance of Remission in Wegener's Granulomatosis and Microscopic Polyangiitis
Status: Enrolling
Updated: 11/27/2017
GSK Investigational Site
mi
from
Kansas City, KA
Click here to add this to my saved trials
Belimumab in Remission of VASculitis
A Phase 3, Multi-Center, Multinational, Randomized, Double-Blind, Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) in Combination With Azathioprine for the Maintenance of Remission in Wegener's Granulomatosis and Microscopic Polyangiitis
Status: Enrolling
Updated:  11/27/2017
GSK Investigational Site
mi
from
Boston, MA
Belimumab in Remission of VASculitis
A Phase 3, Multi-Center, Multinational, Randomized, Double-Blind, Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) in Combination With Azathioprine for the Maintenance of Remission in Wegener's Granulomatosis and Microscopic Polyangiitis
Status: Enrolling
Updated: 11/27/2017
GSK Investigational Site
mi
from
Boston, MA
Click here to add this to my saved trials
Belimumab in Remission of VASculitis
A Phase 3, Multi-Center, Multinational, Randomized, Double-Blind, Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) in Combination With Azathioprine for the Maintenance of Remission in Wegener's Granulomatosis and Microscopic Polyangiitis
Status: Enrolling
Updated:  11/27/2017
GSK Investigational Site
mi
from
West Springfield, MA
Belimumab in Remission of VASculitis
A Phase 3, Multi-Center, Multinational, Randomized, Double-Blind, Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) in Combination With Azathioprine for the Maintenance of Remission in Wegener's Granulomatosis and Microscopic Polyangiitis
Status: Enrolling
Updated: 11/27/2017
GSK Investigational Site
mi
from
West Springfield, MA
Click here to add this to my saved trials
Belimumab in Remission of VASculitis
A Phase 3, Multi-Center, Multinational, Randomized, Double-Blind, Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) in Combination With Azathioprine for the Maintenance of Remission in Wegener's Granulomatosis and Microscopic Polyangiitis
Status: Enrolling
Updated:  11/27/2017
GSK Investigational Site
mi
from
Detroit, MI
Belimumab in Remission of VASculitis
A Phase 3, Multi-Center, Multinational, Randomized, Double-Blind, Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) in Combination With Azathioprine for the Maintenance of Remission in Wegener's Granulomatosis and Microscopic Polyangiitis
Status: Enrolling
Updated: 11/27/2017
GSK Investigational Site
mi
from
Detroit, MI
Click here to add this to my saved trials
Belimumab in Remission of VASculitis
A Phase 3, Multi-Center, Multinational, Randomized, Double-Blind, Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) in Combination With Azathioprine for the Maintenance of Remission in Wegener's Granulomatosis and Microscopic Polyangiitis
Status: Enrolling
Updated:  11/27/2017
GSK Investigational Site
mi
from
Rochester, MN
Belimumab in Remission of VASculitis
A Phase 3, Multi-Center, Multinational, Randomized, Double-Blind, Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) in Combination With Azathioprine for the Maintenance of Remission in Wegener's Granulomatosis and Microscopic Polyangiitis
Status: Enrolling
Updated: 11/27/2017
GSK Investigational Site
mi
from
Rochester, MN
Click here to add this to my saved trials
Belimumab in Remission of VASculitis
A Phase 3, Multi-Center, Multinational, Randomized, Double-Blind, Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) in Combination With Azathioprine for the Maintenance of Remission in Wegener's Granulomatosis and Microscopic Polyangiitis
Status: Enrolling
Updated:  11/27/2017
GSK Investigational Site
mi
from
Camden, NJ
Belimumab in Remission of VASculitis
A Phase 3, Multi-Center, Multinational, Randomized, Double-Blind, Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) in Combination With Azathioprine for the Maintenance of Remission in Wegener's Granulomatosis and Microscopic Polyangiitis
Status: Enrolling
Updated: 11/27/2017
GSK Investigational Site
mi
from
Camden, NJ
Click here to add this to my saved trials
Belimumab in Remission of VASculitis
A Phase 3, Multi-Center, Multinational, Randomized, Double-Blind, Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) in Combination With Azathioprine for the Maintenance of Remission in Wegener's Granulomatosis and Microscopic Polyangiitis
Status: Enrolling
Updated:  11/27/2017
GSK Investigational Site
mi
from
Great Neck, NY
Belimumab in Remission of VASculitis
A Phase 3, Multi-Center, Multinational, Randomized, Double-Blind, Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) in Combination With Azathioprine for the Maintenance of Remission in Wegener's Granulomatosis and Microscopic Polyangiitis
Status: Enrolling
Updated: 11/27/2017
GSK Investigational Site
mi
from
Great Neck, NY
Click here to add this to my saved trials
Belimumab in Remission of VASculitis
A Phase 3, Multi-Center, Multinational, Randomized, Double-Blind, Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) in Combination With Azathioprine for the Maintenance of Remission in Wegener's Granulomatosis and Microscopic Polyangiitis
Status: Enrolling
Updated:  11/27/2017
GSK Investigational Site
mi
from
New York, NY
Belimumab in Remission of VASculitis
A Phase 3, Multi-Center, Multinational, Randomized, Double-Blind, Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) in Combination With Azathioprine for the Maintenance of Remission in Wegener's Granulomatosis and Microscopic Polyangiitis
Status: Enrolling
Updated: 11/27/2017
GSK Investigational Site
mi
from
New York, NY
Click here to add this to my saved trials
Belimumab in Remission of VASculitis
A Phase 3, Multi-Center, Multinational, Randomized, Double-Blind, Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) in Combination With Azathioprine for the Maintenance of Remission in Wegener's Granulomatosis and Microscopic Polyangiitis
Status: Enrolling
Updated:  11/27/2017
GSK Investigational Site
mi
from
Columbus, OH
Belimumab in Remission of VASculitis
A Phase 3, Multi-Center, Multinational, Randomized, Double-Blind, Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) in Combination With Azathioprine for the Maintenance of Remission in Wegener's Granulomatosis and Microscopic Polyangiitis
Status: Enrolling
Updated: 11/27/2017
GSK Investigational Site
mi
from
Columbus, OH
Click here to add this to my saved trials
Belimumab in Remission of VASculitis
A Phase 3, Multi-Center, Multinational, Randomized, Double-Blind, Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) in Combination With Azathioprine for the Maintenance of Remission in Wegener's Granulomatosis and Microscopic Polyangiitis
Status: Enrolling
Updated:  11/27/2017
GSK Investigational Site
mi
from
Portland, OR
Belimumab in Remission of VASculitis
A Phase 3, Multi-Center, Multinational, Randomized, Double-Blind, Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) in Combination With Azathioprine for the Maintenance of Remission in Wegener's Granulomatosis and Microscopic Polyangiitis
Status: Enrolling
Updated: 11/27/2017
GSK Investigational Site
mi
from
Portland, OR
Click here to add this to my saved trials
Belimumab in Remission of VASculitis
A Phase 3, Multi-Center, Multinational, Randomized, Double-Blind, Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) in Combination With Azathioprine for the Maintenance of Remission in Wegener's Granulomatosis and Microscopic Polyangiitis
Status: Enrolling
Updated:  11/27/2017
GSK Investigational Site
mi
from
Philadelphia, PA
Belimumab in Remission of VASculitis
A Phase 3, Multi-Center, Multinational, Randomized, Double-Blind, Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) in Combination With Azathioprine for the Maintenance of Remission in Wegener's Granulomatosis and Microscopic Polyangiitis
Status: Enrolling
Updated: 11/27/2017
GSK Investigational Site
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Belimumab in Remission of VASculitis
A Phase 3, Multi-Center, Multinational, Randomized, Double-Blind, Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) in Combination With Azathioprine for the Maintenance of Remission in Wegener's Granulomatosis and Microscopic Polyangiitis
Status: Enrolling
Updated:  11/27/2017
GSK Investigational Site
mi
from
Pittsburgh, PA
Belimumab in Remission of VASculitis
A Phase 3, Multi-Center, Multinational, Randomized, Double-Blind, Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) in Combination With Azathioprine for the Maintenance of Remission in Wegener's Granulomatosis and Microscopic Polyangiitis
Status: Enrolling
Updated: 11/27/2017
GSK Investigational Site
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Belimumab in Remission of VASculitis
A Phase 3, Multi-Center, Multinational, Randomized, Double-Blind, Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) in Combination With Azathioprine for the Maintenance of Remission in Wegener's Granulomatosis and Microscopic Polyangiitis
Status: Enrolling
Updated:  11/27/2017
GSK Investigational Site
mi
from
Wyomissing, PA
Belimumab in Remission of VASculitis
A Phase 3, Multi-Center, Multinational, Randomized, Double-Blind, Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) in Combination With Azathioprine for the Maintenance of Remission in Wegener's Granulomatosis and Microscopic Polyangiitis
Status: Enrolling
Updated: 11/27/2017
GSK Investigational Site
mi
from
Wyomissing, PA
Click here to add this to my saved trials
Belimumab in Remission of VASculitis
A Phase 3, Multi-Center, Multinational, Randomized, Double-Blind, Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) in Combination With Azathioprine for the Maintenance of Remission in Wegener's Granulomatosis and Microscopic Polyangiitis
Status: Enrolling
Updated:  11/27/2017
GSK Investigational Site
mi
from
Milwaukee, WI
Belimumab in Remission of VASculitis
A Phase 3, Multi-Center, Multinational, Randomized, Double-Blind, Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) in Combination With Azathioprine for the Maintenance of Remission in Wegener's Granulomatosis and Microscopic Polyangiitis
Status: Enrolling
Updated: 11/27/2017
GSK Investigational Site
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Belimumab in Remission of VASculitis
A Phase 3, Multi-Center, Multinational, Randomized, Double-Blind, Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) in Combination With Azathioprine for the Maintenance of Remission in Wegener's Granulomatosis and Microscopic Polyangiitis
Status: Enrolling
Updated:  11/27/2017
GSK Investigational Site
mi
from
Chicago, IL
Belimumab in Remission of VASculitis
A Phase 3, Multi-Center, Multinational, Randomized, Double-Blind, Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) in Combination With Azathioprine for the Maintenance of Remission in Wegener's Granulomatosis and Microscopic Polyangiitis
Status: Enrolling
Updated: 11/27/2017
GSK Investigational Site
mi
from
Chicago, IL
Click here to add this to my saved trials
Belimumab in Remission of VASculitis
A Phase 3, Multi-Center, Multinational, Randomized, Double-Blind, Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) in Combination With Azathioprine for the Maintenance of Remission in Wegener's Granulomatosis and Microscopic Polyangiitis
Status: Enrolling
Updated:  11/27/2017
GSK Investigational Site
mi
from
Mobile, AL
Belimumab in Remission of VASculitis
A Phase 3, Multi-Center, Multinational, Randomized, Double-Blind, Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) in Combination With Azathioprine for the Maintenance of Remission in Wegener's Granulomatosis and Microscopic Polyangiitis
Status: Enrolling
Updated: 11/27/2017
GSK Investigational Site
mi
from
Mobile, AL
Click here to add this to my saved trials
Study Evaluating Intravitreal hI-con1™ in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration
A Phase 2 Randomized, Double-masked, Multicenter, Active-controlled Study Evaluating Administration of Repeated Intravitreal Doses of hI-con1™ in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration
Status: Enrolling
Updated:  11/28/2017
Clinical Research Facility
mi
from
Phoenix, AZ
Study Evaluating Intravitreal hI-con1™ in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration
A Phase 2 Randomized, Double-masked, Multicenter, Active-controlled Study Evaluating Administration of Repeated Intravitreal Doses of hI-con1™ in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration
Status: Enrolling
Updated: 11/28/2017
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Study Evaluating Intravitreal hI-con1™ in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration
A Phase 2 Randomized, Double-masked, Multicenter, Active-controlled Study Evaluating Administration of Repeated Intravitreal Doses of hI-con1™ in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration
Status: Enrolling
Updated:  11/28/2017
Clinical Research Facility
mi
from
Phoenix, AZ
Study Evaluating Intravitreal hI-con1™ in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration
A Phase 2 Randomized, Double-masked, Multicenter, Active-controlled Study Evaluating Administration of Repeated Intravitreal Doses of hI-con1™ in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration
Status: Enrolling
Updated: 11/28/2017
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Study Evaluating Intravitreal hI-con1™ in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration
A Phase 2 Randomized, Double-masked, Multicenter, Active-controlled Study Evaluating Administration of Repeated Intravitreal Doses of hI-con1™ in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration
Status: Enrolling
Updated:  11/28/2017
Clinical Research Facility
mi
from
Arcadia, CA
Study Evaluating Intravitreal hI-con1™ in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration
A Phase 2 Randomized, Double-masked, Multicenter, Active-controlled Study Evaluating Administration of Repeated Intravitreal Doses of hI-con1™ in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration
Status: Enrolling
Updated: 11/28/2017
Clinical Research Facility
mi
from
Arcadia, CA
Click here to add this to my saved trials
Study Evaluating Intravitreal hI-con1™ in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration
A Phase 2 Randomized, Double-masked, Multicenter, Active-controlled Study Evaluating Administration of Repeated Intravitreal Doses of hI-con1™ in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration
Status: Enrolling
Updated:  11/28/2017
Clinical Research Facility
mi
from
Beverly Hills, CA
Study Evaluating Intravitreal hI-con1™ in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration
A Phase 2 Randomized, Double-masked, Multicenter, Active-controlled Study Evaluating Administration of Repeated Intravitreal Doses of hI-con1™ in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration
Status: Enrolling
Updated: 11/28/2017
Clinical Research Facility
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Study Evaluating Intravitreal hI-con1™ in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration
A Phase 2 Randomized, Double-masked, Multicenter, Active-controlled Study Evaluating Administration of Repeated Intravitreal Doses of hI-con1™ in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration
Status: Enrolling
Updated:  11/28/2017
Clinical Research Facility
mi
from
Campbell, CA
Study Evaluating Intravitreal hI-con1™ in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration
A Phase 2 Randomized, Double-masked, Multicenter, Active-controlled Study Evaluating Administration of Repeated Intravitreal Doses of hI-con1™ in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration
Status: Enrolling
Updated: 11/28/2017
Clinical Research Facility
mi
from
Campbell, CA
Click here to add this to my saved trials